Live Breaking News & Updates on Sldb

Stay informed with the latest breaking news from Sldb on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Sldb and stay connected to the pulse of your community

Comparing Ambrx Biopharma (NYSE:AMAM) and Solid Biosciences (NASDAQ:SLDB)

Solid Biosciences (NASDAQ:SLDB – Get Free Report) and Ambrx Biopharma (NYSE:AMAM – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, profitability and valuation. Profitability This table compares Solid Biosciences and […]

Charlestown , Massachusetts , United-states , La-jolla , California , Ambrx-biopharma , Solid-biosciences-inc , Ambrx-biopharma-inc , Ultragenyx-pharmaceutical-inc , Solid-biosciences , Get-free-report , Given-solid-bioscience

Solid Biosciences Inc. (NASDAQ:SLDB) Given Consensus Rating of "Buy" by Brokerages

Shares of Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) have received a consensus rating of “Buy” from the six research firms that are covering the company, Marketbeat reports. Six analysts have rated the stock with a buy recommendation. The average 1 year price target among brokers that have updated their coverage on the stock […]

United-states , Piper-sandler , Kevin-tan , William-blair , Asset-management-inc , Citigroup , Vanguard-group-inc , Solid-biosciences-company-profile , Solid-biosciences-inc , Perceptive-advisors-llc , Nasdaq , Dimensional-fund-advisors

Immunovant (NASDAQ:IMVT) & Solid Biosciences (NASDAQ:SLDB) Critical Comparison

Solid Biosciences (NASDAQ:SLDB – Get Free Report) and Immunovant (NASDAQ:IMVT – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability. Profitability This table compares Solid Biosciences and Immunovant’s net […]

United-states , New-york , Massachusetts , Charlestown , Immunovant-inc , Roivant-sciences-ltd , Ultragenyx-pharmaceutical-inc , Solid-biosciences-inc , Solid-biosciences , Get-free-report , Given-immunovant

Insider Selling: Solid Biosciences Inc. (NASDAQ:SLDB) CFO Sells 3,935 Shares of Stock

Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) CFO Kevin Tan sold 3,935 shares of the company’s stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $8.20, for a total value of $32,267.00. Following the sale, the chief financial officer now directly owns 9,308 shares in the […]

United-states , Kevin-tan , Charles-schwab-investment-management-inc , Prudential-financial-inc , Nasdaq , Solid-biosciences-inc , Geode-capital-management , Asset-management-inc , Securities-exchange-commission , Cantor-fitzgerald , Atria-wealth-solutions-inc , Solid-biosciences-company-profile

Insider Selling: Solid Biosciences Inc. (NASDAQ:SLDB) COO Sells $14,920.26 in Stock

Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) COO David T. Howton sold 5,367 shares of Solid Biosciences stock in a transaction on Monday, December 4th. The stock was sold at an average price of $2.78, for a total value of $14,920.26. Following the sale, the chief operating officer now owns 7,684 shares in the […]

United-states , Davidt-howton , Charles-schwab-investment-management-inc , Solid-biosciences-inc , Atria-wealth-solutions-inc , Prudential-financial-inc , Cantor-fitzgerald , Asset-management-inc , Nasdaq , Mirabella-financial-services , Solid-biosciences

Jessie Hanrahan Sells 4,879 Shares of Solid Biosciences Inc. (NASDAQ:SLDB) Stock

Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) insider Jessie Hanrahan sold 4,879 shares of Solid Biosciences stock in a transaction that occurred on Monday, December 4th. The stock was sold at an average price of $2.78, for a total value of $13,563.62. Following the transaction, the insider now owns 6,983 shares of the company’s […]

United-states , Jessie-hanrahan , Asset-management-inc , Solid-biosciences-inc , Solid-biosciences-company-profile , Atria-wealth-solutions-inc , Prudential-financial-inc , Charles-schwab-investment-management-inc , Mirabella-financial-services , Nasdaq , Cantor-fitzgerald , Solid-biosciences

Comparing Finch Therapeutics Group (NASDAQ:FNCH) and Solid Biosciences (NASDAQ:SLDB)

Solid Biosciences (NASDAQ:SLDB – Get Free Report) and Finch Therapeutics Group (NASDAQ:FNCH – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk. Profitability This table compares Solid Biosciences […]

Massachusetts , United-states , Charlestown , Skysong-innovations , Finch-therapeutics-group , Ultragenyx-pharmaceutical-inc , University-of-minnesota , Solid-biosciences-inc , Given-finch-therapeutics-group , Takeda-pharmaceutical-company , Finch-therapeutics-group-inc

Stocks to Watch: Getty Images, TherapeuticsMD, Solid Biosciences

By Denny Jacob Getty Images Holdings lowered its 2023 outlook, citing challenges ranging from strikes in Hollywood to a stronger dollar. Shares retreat 5.8%...

Hollywood , California , United-states , Denny-jacob , Drug-administration , Getty-images-holdings , Images-holdings , Duchenne-muscular-dystrophy , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences

Solid Biosciences Shares Rise 27% as FDA Clears IND for Muscular Dystrophy Therapy

By Stephen Nakrosis Shares of Solid Biosciences were trading higher in Tuesday's after-hours market, following news the U.S. Food and Drug Administration...

Stephen-nakrosis , Drug-administration , Solid-biosciences , Duchenne-muscular-dystrophy , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Biological-therapy , Healthcare-provision , Financial-performance

Solid Biosciences Inc. (NASDAQ:SLDB) Sees Significant Decrease in Short Interest

Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) was the target of a large decrease in short interest in the month of October. As of October 15th, there was short interest totalling 21,500 shares, a decrease of 27.4% from the September 30th total of 29,600 shares. Based on an average trading volume of 23,700 shares, […]

United-states , Solid-biosciences-inc , Prudential-financial-inc , Charles-schwab-investment-management-inc , Atria-wealth-solutions-inc , Cantor-fitzgerald , Mirabella-financial-services , Asset-management-inc , Nasdaq , Solid-biosciences , Get-free-report